THE MCMANUS GROUP

Biopharma

Latest filing Jul 20, 2026

Consulting

$2.6M

Reported income

Medicare/Medicaid leads by disclosed activity

Filings

Most recent on Jul 20, 2026

Clients represented

INFUSION PROVIDERS ALLIANCE leads by reported income

Lobbyists employed

JOHN MCMANUS appears most prominently

$73.5K

Contribution spend

Thomas Earl Emmer leads among recipients

Reported Income Over Time

Annual totals based on disclosed filing amounts.

2026

$2.6M50 filings

Client Portfolio

The clients this firm represents, ranked by disclosed filing amounts.

INFUSION PROVIDERS ALLIANCE

Healthcare

2 filingsLatest Jul 20, 2026

Association representing infusion drug providers.

$180K

LARGE UROLOGY GROUP PRACTICE ASSOCIATION

Healthcare

2 filingsLatest Jul 20, 2026

Client is a membership association for large physician group practices.

What They Lobby On

Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.

Medicare/Medicaid

MMM

45 mentions45 filingsLatest Jul 20, 2026

$1.5M

apportioned income

HOUSE OF REPRESENTATIVES45SENATE45Centers For Medicare and Medicaid Services (CMS)4Health & Human Services, Dept of (HHS)

Government Touchpoints

The entities named in disclosed activities are the clearest available signal for where the firm is directing attention.

01HOUSE OF REPRESENTATIVES

84 mentions

02SENATE

82 mentions

03Centers For Medicare and Medicaid Services (CMS)

4 mentions

04Health & Human Services, Dept of (HHS)

4 mentions

Contribution Recipients

Officials who received contribution dollars disclosed by this firm.

Total contributions

$73.5K

Contribution items

Officials reached

01Thomas Earl Emmer

Representative • Minnesota

$10K

2 items

02Mike Carey

Representative • Ohio

Industry Profile

AI-classified industry allocation based on the firm's filing activity.

Confidence

75%

Industry count

Biopharma

63%

Healthcare

36%

Nonprofit & Advocacy

Registrant industry was derived from the weighted mix of labeled clients across filings, spend, and activity volume.

Recent Filings

The latest disclosures filed by this firm.

ZIMMER BIOMETQ2

2026 second quarter2 issues3 lobbyists

Medicare/MedicaidHealth Issues

$50K

Jul 20, 2026

WEX HEALTHQ2

2026 second quarter2 issues

THE MCMANUS GROUP

Reported Income Over Time

Client Portfolio

What They Lobby On

Medicare/Medicaid

Government Touchpoints

Contribution Recipients

Industry Profile

Recent Filings

Lobbyists Employed

Health Issues

Taxation/Internal Revenue Code

Trade (domestic/foreign)

Budget/Appropriations

Veterans